CAMBRIDGE, Mass. (AP) _ Ironwood Pharmaceuticals Inc. (IRWD) on Tuesday reported a loss of $13.5 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 9 cents. Losses, adjusted for amortization gains and non-recurring gains, were 12 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
The drugmaker posted revenue of $87.5 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $81 million.
For the year, the company reported that its loss narrowed to $81.7 million, or 56 cents per share. Revenue was reported as $274 million.
Ironwood shares have risen 12 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.12, a climb of 99 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IRWD at https://www.zacks.com/ap/IRWD
Keywords: Ironwood Pharmaceuticals, Earnings Report